immunotherapy Flashcards

(15 cards)

1
Q

what are the functions of CD8+ and T cells

A
  • activated by presented antigen
  • produce clone of T cells
  • recognise specific antigen
  • target specific cells
  • self tolerant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the functions of cancer cells

A
  • proliferation
  • create new vasculature
  • spread
  • evade immune killing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are immune check points

A
  • physiological regulatory mechanism
  • evolutionarily conserved
  • regulate hyperactivation of T cells
  • preserve self tolerance while maintaining protection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the names of the immune checkpoints

A
  • CTLA4 and PD-1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what does CTLA4 checkpoint do

A
  • expressed by T regs
  • prevent immune conjugate formation
  • recruit inhibitory effectors
  • mediates internalisation of its ligands
  • competes for co-stimulatory ligands
  • directly antagonises CD28
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is anergy

A

tolerance mechanism where the lymphocyte is functionally inactivated following antigen binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is exhaustion

A

poor effector function due to expression of inhibitory receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the negative regulatory of T cell activation

A

CTLA4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how is anti-CTLA4 treatment used

A
  • enhances antiumoral immunity
  • provides long lasting immune protection
  • anti cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is ipillmumab

A
  • human IgG1k anti-CTLA4 monoclonal antibody
  • for stage 3 and 4 melanoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is tremelimumab

A
  • IgG2 CTLA-4 blocking antibody
  • binding kinetics for antibody dependent cell mediated cytotoxicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is PD1

A
  • putative mediator of apoptosis
  • expressed by human T cells following activation of TCR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is pembrolizumab

A
  • humanised IgG4 antibody targeting PD1
  • for refractory and unresectable melanoma
  • 73% survival rate at a year
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is tisagenlecleucel

A
  • CD19 targeted CAR-T cell therapy
  • CD19 uniformly expressed on B cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what does PD1 limit

A
  • CD8+ antitumour effects
  • suppresses myeloma growth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly